1 option
RU 486 (MifePristone) Conditional Approval by the Food and Drug Administration
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service
- Language:
- English
- Subjects (All):
- Abortion.
- Drugs.
- Family planning.
- Physical Description:
- 1 online resource
- Contained In:
- ProQuest U.S. Congressional Research Digital Collection
- Place of Publication:
- [Washington, D.C.] [publisher not identified] 1997
- Summary:
- Details discovery, research, and marketing of mifepristone, also known as RU 486, a drug that prevents or interrupts a pregnancy. Reviews efficacy and safety considerations of RU 486 and examines provisional FDA approval and related issues
- Notes:
- CRS Report
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC
- Vendor supplied data
- Other Format:
- Microfiche version Library of Congress. Congressional Research Service. RU 486 (MifePristone)
- Publisher Number:
- CRS-1997-SPR-0039
- Access Restriction:
- Restricted for use by site license
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.